Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Yau

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|March 30, 2021
Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
The American Journal of Gastroenterology|September 18, 2013
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutationsDmitri Mouradov, Enric Domingo, Peter Gibbs, et al.
Nature Communications|July 29, 2024
Author Correction: Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelinesAlexander P L Martindale, Carrie D Llewellyn, Richard O de Visser, et al.
Nature Communications|February 22, 2024
Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelinesAlexander P L Martindale, Carrie D Llewellyn, Richard O de Visser, et al.
BMC Pregnancy and Childbirth|February 12, 2022
Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional studySiang Ing Lee, Amaya Azcoaga-Lorenzo, Utkarsh Agrawal, et al.
Gastroenterology|June 20, 2017
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug SensitivityJing Wang, Dmitri Mouradov, Xiaojing Wang, et al.
Cancer Cell|February 13, 2020
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial CellsZhiyuan Hu, Mara Artibani, Abdulkhaliq Alsaadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisionsLena Rai, Antonella Ravaggi, Eliana Bignotti, et al.
BMC Medicine|January 16, 2023
Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019Anuradhaa Subramanian, Amaya Azcoaga-Lorenzo, Astha Anand, et al.
BMJ Open|February 24, 2023
Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UKSiang Ing Lee, Holly Hope, Dermot O'Reilly, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|March 30, 2021
Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
The American Journal of Gastroenterology|September 18, 2013
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutationsDmitri Mouradov, Enric Domingo, Peter Gibbs, et al.
Nature Communications|July 29, 2024
Author Correction: Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelinesAlexander P L Martindale, Carrie D Llewellyn, Richard O de Visser, et al.
Nature Communications|February 22, 2024
Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelinesAlexander P L Martindale, Carrie D Llewellyn, Richard O de Visser, et al.
BMC Pregnancy and Childbirth|February 12, 2022
Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional studySiang Ing Lee, Amaya Azcoaga-Lorenzo, Utkarsh Agrawal, et al.
Gastroenterology|June 20, 2017
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug SensitivityJing Wang, Dmitri Mouradov, Xiaojing Wang, et al.
Cancer Cell|February 13, 2020
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial CellsZhiyuan Hu, Mara Artibani, Abdulkhaliq Alsaadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisionsLena Rai, Antonella Ravaggi, Eliana Bignotti, et al.
BMC Medicine|January 16, 2023
Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019Anuradhaa Subramanian, Amaya Azcoaga-Lorenzo, Astha Anand, et al.
BMJ Open|February 24, 2023
Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UKSiang Ing Lee, Holly Hope, Dermot O'Reilly, et al.
Pageof 9